Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Fucoidan reduces bone cell formation by affecting T-cell activity.

The study suggests hormonal factors may play a role in Frontal Fibrosing Alopecia and that treatments like oral antiandrogens and steroids could be beneficial.

Trichoscopy of the beard is useful for diagnosing frontal fibrosing alopecia in men.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

Frontal fibrosing alopecia causes hair loss at the front hairline, and no effective treatment exists.

The article suggests that patients with Frontal Fibrosing Alopecia may have more contact allergies, but it doesn't prove that allergies cause the condition.

Tofacitinib is effective for treating alopecia totalis and universalis, with some patients experiencing significant hair regrowth.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Familial frontal fibrosing alopecia affects premenopausal women too, and early diagnosis is important, but no proven medication exists yet.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Increased sunscreen use may be linked to frontal fibrosing alopecia in Hispanic females.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Frontal fibrosing alopecia can be diagnosed by examining facial areas and treated with specific medications to stop its progression.

Special immune cells called Tregs can help prevent lung scarring by blocking a specific growth factor.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Frontal fibrosing alopecia has occurred in two related male families.

The pedicled temporoparietal fascial flap is a reliable and versatile option for reconstructive surgery in the head and neck area.

Hair transplantation may not work for Frontal Fibrosing Alopecia as transplanted hair was lost when the disease came back.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.